Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview
- PMID: 11786514
- DOI: 10.1161/hh0102.102330
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview
Abstract
Nitric oxide (NO) mediates multiple physiological and pathophysiological processes in the cardiovascular system. Pharmacological compounds that release NO have been useful tools for evaluating the pivotal role of NO in cardiovascular physiology and therapeutics. These agents constitute two broad classes of compounds, those that release NO or one of its redox congeners spontaneously and those that require enzymatic metabolism to generate NO. In addition, several commonly used cardiovascular drugs exert their beneficial action, in part, by modulating the NO pathway. Here, we review these classes of agents, summarizing their fundamental chemistry and pharmacology, and provide an overview of their cardiovascular mechanisms of action.
Similar articles
-
Nitric oxide-releasing drugs.Annu Rev Pharmacol Toxicol. 2003;43:97-123. doi: 10.1146/annurev.pharmtox.43.100901.140226. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12540742 Review.
-
Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties.Curr Pharm Des. 2009;15(6):614-36. doi: 10.2174/138161209787315611. Curr Pharm Des. 2009. PMID: 19199986 Review.
-
NO-releasing hybrids of cardiovascular drugs.Curr Med Chem. 2006;13(6):609-25. doi: 10.2174/092986706776055634. Curr Med Chem. 2006. PMID: 16529554 Review.
-
Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.Pharmacol Res. 2020 Sep;159:104961. doi: 10.1016/j.phrs.2020.104961. Epub 2020 May 29. Pharmacol Res. 2020. PMID: 32474086 Review.
-
Distribution of nitric oxide in cardiovascular system.Physiol Res. 1997;46(4):243-9. Physiol Res. 1997. PMID: 9728489
Cited by
-
S-Nitrosoglutathione Reduces the Density of Staphylococcus aureus Biofilms Established on Human Airway Epithelial Cells.ACS Omega. 2022 Dec 28;8(1):846-856. doi: 10.1021/acsomega.2c06212. eCollection 2023 Jan 10. ACS Omega. 2022. PMID: 36643497 Free PMC article.
-
The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.Biochem Pharmacol. 2020 Jun;176:113931. doi: 10.1016/j.bcp.2020.113931. Epub 2020 Mar 26. Biochem Pharmacol. 2020. PMID: 32224139 Free PMC article. Review.
-
Topical combinations to treat microvascular dysfunction of chronic postischemia pain.Anesth Analg. 2014 Apr;118(4):830-40. doi: 10.1213/ANE.0000000000000141. Anesth Analg. 2014. PMID: 24651238 Free PMC article.
-
Trends in H2S-Donors Chemistry and Their Effects in Cardiovascular Diseases.Antioxidants (Basel). 2021 Mar 11;10(3):429. doi: 10.3390/antiox10030429. Antioxidants (Basel). 2021. PMID: 33799669 Free PMC article. Review.
-
Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.Mol Cell Biol. 2013 Aug;33(16):3321-9. doi: 10.1128/MCB.00432-13. Epub 2013 Jun 17. Mol Cell Biol. 2013. PMID: 23775121 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources